News about Biotechnology

TriLink Signs Non-Exclusive License and Supply Agreement with Lonza

TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.

Biotechnology | 02/05/2024 | By Aishwarya |  676

INTEGRA Biosciences Launches MAG and HEATMAG Modules for Magnetic Bead Purification

These innovative solutions allow researchers to streamline several processing steps in molecular biology and proteomics workflows for maximum lab throughput.

Biotechnology | 23/02/2024 | By Manvi |  489

ABL Medical Developing Anti-Microbial Blue Light Fiber Technology

ABL Medical has now demonstrated the potential for blue light fiber-optic technology to combat microbial infections.

Biotechnology | 10/02/2024 | By Manvi |  465

MicrofluidX Announces Joint Research Project with Immatics for Automated End-to-End Bioprocessing for TCR-T Therapies

MicrofluidX announces a joint research project with Immatics to combine Immatics’ manufacturing of TCR-T cells with MicrofluidX’s innovative new platform, the Cyto Engine™.

Biotechnology | 03/05/2023 | By Manvi |  831

Novartis to invest $300 M in biologics manufacturing and development operations

The company plans to establish a biologics hub at its Basel, Switzerland campus

Biotechnology | 14/09/2022 | By Sudeep Soparkar |  737

Astellas plans to open biotech campus in South San Francisco

Astellas will invest approximately $70 million to create the new state-of-the-art facility, which will provide lab and co-working spaces to accommodate future growth

Biotechnology | 22/07/2022 | By Sudeep Soparkar |  1219

Merck unveils microbiology application lab in Jigani, Bengaluru

Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani

Biotechnology | 21/07/2022 | By Sudeep Soparkar |  1175

KBI Biopharma, Selexis open expanded facility in Geneva, Switzerland

The ~94,000 square-foot facility will house new laboratories to support Selexis’ unique technical cell line workflows and KBI’s process development and cGMP manufacturing

Biotechnology | 11/07/2022 | By Sudeep Soparkar |  903

Two ImmunoINSIGHTS contracts signed by Oncimmune

Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.

Biotechnology | 15/04/2022 | By Sudeep Soparkar |  757

Global diseases treatment with mRNA to be researched by Moderna and IAVI together

Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.

Biotechnology | 12/04/2022 | By Sudeep Soparkar |  724